Current role of magnetic resonance imaging in breast imaging: A primer for the primary care physician

Journal of the American Board of Family Practice

Volumn 18, Issue 6, 2005, Pages 478-490

  Shah, Shinil K ^a,c   Shah, Shiwan K ^a   Greatrex, Kathleen V ^b  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b OUR LADY OF LOURDES MEDICAL CENTER   (United States)

^c 1510 Cherrywood Apartments ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAT;

ARTICLE; BREAST CANCER; BREAST ENDOPROSTHESIS; BREAST EXAMINATION; DIAGNOSTIC ACCURACY; FAT CONTENT; HUMAN; IMAGE QUALITY; MENSTRUAL CYCLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICIAN; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; SCREENING; SENSITIVITY AND SPECIFICITY; VELOCITY;

EID: 29244447708     PISSN: 08938652     EISSN: 15448770     Source Type: Journal    
DOI: 10.3122/jabfm.18.6.478     Document Type: Article

References (60)

1. Rankin SC. MRI of the breast. Br J Radiol 2000;73: 806-18.
2. Majid AS, de Paredes ES, Doherty RD, et al. Missed breast carcinoma: pitfalls and pearls. Radiographics. 2003;23:881-95.
3. Doi K, MacMahon H, Katsuragawa S, et al. Computer-aided diagnosis in radiology: potential and pitfalls. Eur J Radiol 1997;31:97-109.
4. Plevritis SK, Ikeda DM. Ethical issues in contrast-enhanced magnetic resonance imaging screening for breast cancer. Top Magn Reson Imaging 2002;13: 79-84.
5. Heywang-Kobrunner SH, Viehweg P, Heinig A, Kuchler C. Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. Eur J Radiol 1997;24:94-108.
6. Bluemke DA, Gatsonis CA, Chen MH, et al. Magnetic resonance imaging of the breast prior to biopsy. JAMA 2004;292:2375-742.
7. Brant WE. Diagnostic imaging methods. In: Brant WE, Helms CA, editors. Fundamentals of Diagnostic Radiology, 2nd ed. Philadelphia (PA): Lippincott Williams and Wilkins; 1999. p. 19.
8. Ose K, Doue T, Zen K, et al. Gadolinium as an alternative to iodinated contrast media for x-ray angiography in patients with severe allergy. Circ J 2005;69:507-9.
9. Sam AD II, Morasch MD, Collins J, et al. Safety of gadolinium contrast angiography in patients with chronic renal insufficiency. J Vasc Surg 2003;38: 313-8.
10. Thomsen HS. Gadolinium-based contrast media may be nephrotoxic even at approved doses. Eur Radiol 2004;14:1654-6.
11. Morris EA. Breast cancer imaging with MRI. Radiol Clin North Am 2002;40:443-66.
12. Iglehart DJ, Kaelin CM. Diseases of the breast. In: Townsend CM, Beauchamp RD, Evers BM, Mattox KL, editors. Sabiston Textbook of Surgery 17th ed. Philadelphia (PA): Elsevier; 2004. p. 867.
13. Feig SA, Orel SG, Dershaw DD. The breast. In: Grainger RG, Allison D, Adam A, Dixon AK, editors. Grainger & Allison's Diagnostic Radiology: A Textbook of Medical Imaging, 4th ed. Orlando (FL): Churchill Livingstone; 2001. p. 2268-72.
14. Kinkel K, Hylton N. Challenges to interpretation of breast MRI. J Magn Reson Imaging 2001;13:821-9.
15. Schnall MD, Ikeda DM. Lesion diagnosis working group report. J Magn Reson Imaging 1999;10:982-90.
16. Kinkel K, Vlastos G. MR imaging: breast cancer staging and screening. Semin Surg Oncol 2001;20: 187-96.
17. Schelfout K, Van Goethem M, Kersschot E, et al. Contrast-enhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol 2004;30: 501-7.
18. Bedrosian I, Mick R, Orel SG, et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 2003;98:468-73.
19. Riber A, Schirrmeister H, Gabelmann A, et al. Preoperative staging of invasive breast cancer with MR mammography and/or PET: boon or bunk?. Br J Radiol 2002;75:789-98.
20. Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 1999; 213:881-8.
21. Esserman L, Hylton N, Yassa L, et al. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol 1999;17:110-9.
22. Rodenko GN, Harms SE, Pruneda JM, et al. MR imaging in the management before surgery of lobular carcinoma of the breast: correlation with pathology. AJR 1996;167:1415-9.
23. Boetes C, Veltman J, van Die L, et al. The role of MRI in invasive lobular carcinoma. Breast Cancer Res Treat 2004;86:31-7.
24. Van Goethem M, Schelfout K, Dijckmans L, et al. MR mammography in the preoperative staging of breast cancer in patients with dense breast tissue: comparison with mammography and ultrasound. Eur Radiol 2004;14:809-16.
25. Yeh E, Slanetz P, Kopans DB, et al. Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR 2005;184: 868-77.
26. Chen X, Moore MO, Lehman CD, et al. Combined use of MRI and PET to monitor response and assess residual disease for locally advanced breast cancer treated with neoadjuvant chemotherapy. Acad Radiol 2004;11:1115-24.
27. Denis F, Desbiez-Bourcier AV, Chapiron C, et al. Contrast enhanced magnetic resonance image underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer. Eur J Surg Oncol 2004;30:1069-76.
28. Tozaki M, Uno S, Kobayashi T. Histologic breast cancer extent after neoadjuvant chemotherapy: comparison with multidetector-row CT and dynamic MRI. Radiat Med 2004;22:246-53.
29. Bodini M, Berruti A, Bottini A, et al. Magnetic resonance imaging in comparison to clinical palpation in assessing the response of breast cancer to epirubicin primary chemotherapy [abstract]. Breast Cancer Res Treat 2004;85:211-8.
30. Warren RM, Bobrow LG, Earl HM, et al. Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy? Br J Cancer 2004;90:1349-60.
31. Lee JM, Orel SG, Czerniecki BJ, et al. MRI before reexcision surgery in patients with breast cancer. AJR 2004;182:473-80.
32. Rosen EL, Blackwell KL, Baker JA, et al. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR 2003;181:1275-82.
33. Hwang ES, Kinkel K, Esserman LJ, et al. Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: value in the diagnosis of residual disease, occult invasion, and multicentricity. Ann Surg Oncol 2003;10:381-8.
34. Belli P, Romani M, Costantini M, et al. Role of magnetic resonance imaging in the pre and postchemotherapy evaluation in locally advanced breast carcinoma [abstract]. Rays 2002;27:279-90.
35. Cheung YC, Chen SC, Su MY, et al. Monitoring the size and response of locally advanced breast cancer to neoadjuvant chemotherapy (weekly paclitaxel and epifubicin) with serial enhanced MRI. Breast Cancer Res Treat 2003;78:51-8.
36. Partridge SC, Gibbs JE, Lu Y, et al. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR 2002;179:1193-9.
37. Kawashima H, Tawara M, Suzuki M, et al. Effectiveness of dynamic MRI for diagnosing pericicatricial minimal residual breast cancer following excisional biopsy. Eur J Radiol 2001;40:2-9.
38. Drew PJ, Kerin MJ, Mahapatra T, et al. Evaluation of response to neoadjuvant chemoradiotherapy for locally advanced breast cancer with dynamic contrast-enhanced MRI of the breast. Eur J Surg Oncol 2001;27:617-20.
39. Weatherall PT, Evans GF, Metzger GJ. MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with x-ray mammography and palpation. J Magn Reson Imaging 2001;13: 868-75.
40. Frei KA, Kinkel K, Boenl HM, et al. MR imaging of the breast in patients with positive margins after lumpectomy: influence of the time interval between lumpectomy and MR imaging. AJR 2000;175:1577-84.
41. Trecate G, Ceglia E, Stabile F, et al. Locally advanced breast cancer treated with primary chemotherapy: comparison between magnetic resonance imaging and pathological evaluation of residual disease [abstract]. Tumori 1999;85:220-8.
42. Orel Sg, Reynolds C, Schnall MD, et al. Breast carcinoma: MR imaging before re-excisional biopsy. Radiology 1997;205:429-36.
43. Soderstrom CE, Harms SE, Farrell RS, et al. Detection with MR imaging of residual tumor in the breast soon after surgery. AJR 1997;168:485-8.
44. Fischer U, Zachariae O, Baum F, et al. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer [abstract]. Eur Radiol 2004;14:1725-31.
45. Olson JA, Jr., Morris EA, Van Zee KJ, et al. Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann Surg Oncol 2000; 7:411-5.
46. Henry-Tillman RS, Harms SE, Westbrook KC, et al. Role of breast magnetic resonance imaging in determining breast as a source of unknown metastatic lymphadenopathy. Am J Surg 1999;178:496-500.
47. Orel SG, Weinstein SP, Schnall MD, et al. Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology 1999; 212:543-9.
48. Lindfors KK. Breast imaging. In: Brant WE, Helms CA, editors. Fundamentals of Diagnostic Radiology, 2nd ed. Philadelphia (PA): Lippincott Williams and Wilkins; 1999. p. 493, 512-3.
49. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004;292:1317-25.
50. Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004;351:427-37.
51. Imaginis. Magnetic resonance breast imaging (MRI, MR). May 2005. Available at: http://imaginis.com/ breasthealth/mri.asp. Accessed on: June 3, 2005.
52. Breast Cancer Action. Newsletter #39-December 1996/January 1997. Available at: http://www. bcaction.org/Pages/SearchablePages/1996Newsletters/ Newsletter039G.html. Accessed on: June 3, 2005.
53. Mettler FA. Essentials of Radiology, 2nd ed. Philadelphia (PA): Elsevier; 2005. p. 401.
54. Morris EA, Liberman L, Ballon DJ, et al. MRI of occult breast carcinoma in a high risk population. AJR 2003;181:619-26.
55. Leach MO, Boggis CR, Dixon AK, et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 2005;365:1679-78.
56. Lehman CD, Blume JD, Weatherall P, et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer. 2005;103:1898-905.
57. Podo F, Sardanelli F, Canese R, et al. The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk [abstract]. J Exp Clin Cancer Res 2002;21(3 Suppl):115-24.
58. Sim LS, Hendriks JH, Fook-Chong SM. Breast ultrasound in women with familial risk of breast cancer. Ann Acad Med Singapore. 2004;33:600-6.
59. Warner E. Intensive radiologic surveillance: a focus on the psychological issues [abstract]. Ann Oncol 2004;15 Suppl 1:143-7.
60. Rijnsburger AJ, Essink-Bot ML, van Dooren S, et al. Impact of screening for breast cancer in high-risk women on health-related quality of life. Br J Cancer. 2004;91:69-76.